Biphasic Remogliflozin Etabonate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biphasic Remogliflozin Etabonate, covering 2018-01-18 to 2018-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes [Phase 2]